Efforts to enhance AAV8-mediated gene therapy of Pompe disease

被引:0
|
作者
Zieler, R. [1 ]
Bercury, S. [1 ]
Zhu, Y. [1 ]
Foley, J. [1 ]
Glimlaw, N. [1 ]
Koeberl, D. [2 ]
Scheule, R. [1 ]
Cheng, S. [1 ]
机构
[1] Genzyme Corp, Framingham, MA 01701 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC USA
关键词
D O I
10.1016/j.nmd.2007.06.427
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:890 / 890
页数:1
相关论文
共 50 条
  • [21] Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy
    Hurlbut, Gregory D.
    Ziegler, Robin J.
    Nietupski, Jennifer B.
    Foley, Joseph W.
    Woodworth, Lisa A.
    Meyers, Elizabeth
    Bercury, Scott D.
    Pande, Nilesh N.
    Souza, David W.
    Bree, Mark P.
    Lukason, Michael J.
    Marshall, John
    Cheng, Seng H.
    Scheule, Ronald K.
    MOLECULAR THERAPY, 2010, 18 (11) : 1983 - 1994
  • [22] AAV8-Mediated Gene Therapy Rescues Retinal Degeneration Phenotype in a Tlcd3b Knockout Mouse Model
    Qian, Xinye
    Liu, Hehe
    Fu, Shangyi
    Lu, Jiaxiong
    Hung, Yu-Ting
    Turner, Cassidy
    Gu, Haiwei
    Chen, Rui
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (03)
  • [23] Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia/reperfusion injuries
    Luo, Jing
    Wang, Shengli
    Zhou, Zhenlong
    Zhao, Yin
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 551 - 558
  • [24] Nutritional changes after an AAV8-mediated liver-directed gene therapy in adults with glycogen storage disease type Ia (GSD Ia)
    Saavedra, H.
    Mount, M.
    Lipinski, S.
    Camba-Garea, M-J
    de Boer, F.
    Boney, A.
    Rodriguez-Buritica, D. F.
    Riba-Wolman, R.
    Ahmad, A.
    Couce Pico, M. L.
    Derks, T. G.
    Mitchell, J. J.
    Mitragotri, D.
    Grimm, A. A.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 : 29 - 29
  • [25] Prohypertrophic Agents Enhance the Response to Gene Therapy in Pompe Disease
    Han, Sang-oh
    Li, Songtao
    Koeberl, Dwight D.
    MOLECULAR THERAPY, 2016, 24 : S152 - S152
  • [26] Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)
    Weinstein, David A.
    Derks, Terry G.
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Couce, Maria-Luz
    Mitchell, John J.
    Riba-Wolman, Rebecca
    Mount, Malaya
    Sallago, Julieta Bonvin
    Ross, Katalin M.
    van Der Klauw, Melanie M.
    de Boer, Foekje
    van Der Schaaf, Caroline
    Saavedra, Heather
    Martinez-Olmos, Miguel
    Atanga, Elvis
    Hosseini, Asad
    Mitragotri, Deepali
    Crombez, Eric
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (02)
  • [27] Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity
    Wang, Lizheng
    Wang, Zixuan
    Xu, Xiaoyu
    Zhu, Rui
    Bi, Jinpeng
    Liu, Wenmo
    Feng, Xinyao
    Wu, Hui
    Zhang, Haihong
    Wu, Jiaxin
    Kong, Wei
    Yu, Bin
    Yu, Xianghui
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (04): : 340 - 347
  • [28] Efficacious Androgen Hormone Administration in Combination with AAV Vector-Mediated Gene Therapy in Female Mice with Pompe Disease
    Han, Sang-oh
    Mapatano, Sweet Hope
    Li, Songtao
    Brooks, Elizabeth
    Koeberl, Dwight
    MOLECULAR THERAPY, 2017, 25 (05) : 193 - 194
  • [29] AAV8-Mediated Hepatic Immune Tolerance Permits Redosing of Therapeutic Transgenes
    Muhuri, Manish
    Li, Shaoyong
    Xiao, Yuanyuan
    Wang, Dan
    Xie, Jun
    Li, Jia
    Su, Qin
    Tai, Phillip W. L.
    Gao, Guangping
    MOLECULAR THERAPY, 2019, 27 (04) : 138 - 138
  • [30] AAV8-Mediated Transgene Expression in Mice and Non-Human Primates
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Matsushita, Takashi
    Okada, Takashi
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Sakata, Yoichi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2006, 13 : S3 - S3